Amikacin Dosing Guidelines for Serious Bacterial Infections

Standard Dosing for Normal Renal Function

For complicated intra-abdominal infections, guidelines recommend 15-20 mg/kg every 24 hours with therapeutic drug monitoring 1
The American College of Physicians and other medical societies support once-daily dosing at 15-20 mg/kg for serious infections, as it achieves peak serum levels of approximately 40.9 mg/L 1

Amikacin clearance is almost exclusively renal, requiring dosing adjustments based on creatinine clearance, with a recommended dose of 12-15 mg/kg per administration 2
Reduce dosing frequency to 2-3 times per week in renal impairment, but maintain 12-15 mg/kg per administration to preserve concentration-dependent killing 2
For hemodialysis patients, administer the full dose (12-15 mg/kg) after dialysis sessions to facilitate directly observed therapy and prevent premature drug removal 2, 3

Serum drug concentrations should be obtained routinely to avoid toxicity, with target peak levels around 20 mg/mL for once-daily dosing 4, 5
Monitor renal function closely—nephrotoxicity occurs in 8.7% overall, but only 3.4% in patients without risk factors 2
Monthly monitoring for auditory or vestibular symptoms is recommended, with audiogram and vestibular testing if eighth nerve toxicity symptoms develop 2

No dose adjustment is required for hepatic impairment alone, as amikacin undergoes renal elimination, not hepatic metabolism 2
However, patients with severe hepatic disease require close renal function monitoring due to predisposition to hepatorenal syndrome 2

For complicated intra-abdominal infections, treatment duration should be 4-7 days unless source control is inadequate 1
For nontuberculous mycobacterial infections, minimum treatment duration is 2-4 months for serious disease, 6 months for bone infections 4, 5

Never reduce the per-dose amount in renal insufficiency—only extend the dosing interval while maintaining 12-15 mg/kg per dose 2
Avoid concurrent nephrotoxic agents (NSAIDs, vancomycin, loop diuretics) whenever possible, as this significantly increases nephrotoxicity risk 2
Initial dosing should be based on adjusted body weight (lean body mass), not total body weight, to avoid overdosing in obese patients 1